Features and Outcomes of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study

ConclusionAnakinra was prescribed for cases of refractory crystal-associated arthritis or cases with contraindications for usual treatments. The efficacy of anakinra in treating CCPD was not obvious. Patients with CCPD had more side effects. The biotherapy was introduced with a long-term objective, while anti-IL-1 therapies are approved for acute crises only.

http://link.springer.com/10.1007/s40744-021-00335-7

Source: Rheumatology and Therapy - July 4, 2021 Category: Rheumatology Source Type: research